Farr Miller & Washington’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $5.01M | Buy |
116,383
+95
| +0.1% | +$4.21K | 0.33% | 40 |
|
|
2021
Q2 | $4.55M | Buy |
116,288
+2,860
| +3% | +$111K | 0.3% | 40 |
|
|
2021
Q1 | $4.11M | Buy |
113,428
+2,561
| +2% | +$90.9K | 0.29% | 42 |
|
|
2020
Q4 | $4.08M | Sell |
110,867
-3,498
| -3% | -$128K | 0.31% | 42 |
|
|
2020
Q3 | $3.98M | Buy |
114,365
+14,437
| +14% | +$506K | 0.34% | 40 |
|
|
2020
Q2 | $3.1M | Buy |
99,928
+6,158
| +7% | +$209K | 0.25% | 44 |
|
|
2020
Q1 | $2.9M | Buy |
93,770
+3,644
| +4% | +$124K | 0.27% | 45 |
|
|
2019
Q4 | $3.35M | Buy |
90,126
+3,810
| +4% | +$136K | 0.24% | 46 |
|
|
2019
Q3 | $2.94M | Buy |
86,316
+2,775
| +3% | +$101K | 0.23% | 48 |
|
|
2019
Q2 | $3.43M | Buy |
83,541
+964
| +1% | +$38.3K | 0.28% | 44 |
|
|
2019
Q1 | $3.33M | Hold |
82,577
| – | – | 0.28% | 47 |
|
|
2018
Q4 | $3.42M | Sell |
82,577
-5,294
| -6% | -$220K | 0.33% | 45 |
|
|
2018
Q3 | $3.67M | Sell |
87,871
-3,234
| -4% | -$124K | 0.31% | 43 |
|
|
2018
Q2 | $3.14M | Sell |
91,105
-3,893
| -4% | -$133K | 0.28% | 47 |
|
|
2018
Q1 | $3.2M | Sell |
94,998
-538
| -0.6% | -$18.5K | 0.3% | 44 |
|
|
2017
Q4 | $3.28M | Buy |
95,536
+4,982
| +6% | +$170K | 0.29% | 46 |
|
|
2017
Q3 | $3.07M | Buy |
90,554
+165
| +0.2% | +$5.3K | 0.29% | 45 |
|
|
2017
Q2 | $2.88M | Buy |
90,389
+648
| +0.7% | +$20.4K | 0.28% | 46 |
|
|
2017
Q1 | $2.91M | Sell |
89,741
-1,096
| -1% | -$34.6K | 0.3% | 43 |
|
|
2016
Q4 | $2.8M | Buy |
90,837
+6,758
| +8% | +$206K | 0.3% | 48 |
|
|
2016
Q3 | $2.7M | Sell |
84,079
-317
| -0.4% | -$10.6K | 0.29% | 47 |
|
|
2016
Q2 | $2.82M | Buy |
84,396
+2,264
| +3% | +$72.3K | 0.32% | 45 |
|
|
2016
Q1 | $2.31M | Sell |
82,132
-4,940
| -6% | -$141K | 0.27% | 46 |
|
|
2015
Q4 | $2.67M | Buy |
87,072
+10,618
| +14% | +$334K | 0.32% | 42 |
|
|
2015
Q3 | $2.28M | Sell |
76,454
-5,545
| -7% | -$178K | 0.29% | 45 |
|
|
2015
Q2 | $2.61M | Sell |
81,999
-10,920
| -12% | -$356K | 0.3% | 41 |
|
|
2015
Q1 | $3.07M | Sell |
92,919
-783
| -0.8% | -$24.9K | 0.35% | 39 |
|
|
2014
Q4 | $2.77M | Buy |
93,702
+2,846
| +3% | +$81.6K | 0.32% | 42 |
|
|
2014
Q3 | $2.55M | Sell |
90,856
-4,295
| -5% | -$121K | 0.33% | 42 |
|
|
2014
Q2 | $2.68M | Buy |
95,151
+1,805
| +2% | +$51.5K | 0.34% | 42 |
|
|
2014
Q1 | $2.85M | Sell |
93,346
-701
| -0.7% | -$20.9K | 0.39% | 40 |
|
|
2013
Q4 | $2.73M | Buy |
94,047
+722
| +0.8% | +$21K | 0.38% | 41 |
|
|
2013
Q3 | $2.54M | Sell |
93,325
-5,592
| -6% | -$152K | 0.41% | 40 |
|
|
2013
Q2 | $2.63M | Buy |
+98,917
| New | +$2.73M | 0.43% | 40 |
|
Other funds holding PFE
Farr Miller & Washington's PFE Position: Q3 2021 in Review
Farr Miller & Washington increased its Pfizer (PFE) stake by 0.08% in Q3 2021, buying an estimated $4.21K and bringing the position to 116,383 shares worth $5.01M. The position accounts for 0.33% of the portfolio, ranked #40.
Farr Miller & Washington first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Farr Miller & Washington held 116,383 shares of Pfizer worth $5.01M as of Q3 2021.
- Farr Miller & Washington bought 95 Pfizer shares in Q3 2021, an estimated $4.21K.
- Pfizer made up 0.33% of Farr Miller & Washington's portfolio in Q3 2021, its #40 holding.
- Farr Miller & Washington first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
- 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.